Radiation Oncology Strategic Research Report 2025 | Market to Reach $10.2 Billion by 2030 - Surge in Awareness Campaigns on Early Cancer Detection Supports Growth

Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "Radiation Oncology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Radiation Oncology was estimated at US$7.9 Billion in 2024 and is projected to reach US$10.2 Billion by 2030, growing at a CAGR of 4.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.



The growth in the radiation oncology market is driven by several factors, including the global rise in cancer prevalence, advancements in radiotherapy technologies, and increasing healthcare investments in oncology infrastructure. Rising incidence of complex and treatment-resistant cancers is propelling demand for precision-focused modalities like proton therapy and stereotactic radiotherapy. At the same time, technological convergence between AI, imaging, and radiotherapy is facilitating personalized treatment planning and outcome monitoring, which enhances clinical effectiveness and operational efficiency.

Government funding and public-private partnerships are accelerating the deployment of radiotherapy infrastructure in both developed and emerging regions. Additionally, expanding insurance coverage for advanced radiotherapy procedures and increasing awareness about early cancer detection are supporting treatment uptake. Ongoing clinical trials exploring novel combinations of immunotherapy with radiation are expected to open new therapeutic frontiers in the years ahead. Together, these drivers are positioning radiation oncology not only as a cornerstone of modern cancer therapy but also as a field undergoing continuous technological and clinical innovation, with strong growth prospects globally.

How Is Radiation Oncology Evolving in Response to Cancer Care Demands?

Radiation oncology continues to be a cornerstone in the multidisciplinary management of cancer, with ongoing innovations enhancing both efficacy and precision in targeting malignant tissues. The field has shifted significantly from conventional radiotherapy to highly advanced techniques such as intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), image-guided radiation therapy (IGRT), and proton beam therapy. These modalities allow for accurate dose delivery that spares surrounding healthy tissue, reduces side effects, and improves patient outcomes. Growing cancer incidence worldwide, coupled with an aging population, is pushing healthcare systems to expand radiation oncology infrastructure and capabilities.

The adoption of personalized oncology, where treatment is tailored based on tumor genetics and radiomic data, is further redefining treatment planning. Integration of artificial intelligence and machine learning algorithms into radiation oncology software is facilitating adaptive radiotherapy, which adjusts treatment in real time based on patient response and anatomical changes. Additionally, advancements in radiobiology and hypofractionation protocols are enabling shorter treatment durations with equal or improved efficacy, enhancing both throughput and patient convenience. These developments are driving clinical and operational transformation in radiation oncology centers globally.

Which Technologies and Modalities Are Shaping Modern Radiation Oncology Practice?

Cutting-edge technologies are transforming the landscape of radiation oncology, with linear accelerators (LINACs), proton therapy units, brachytherapy equipment, and robotic radiosurgery platforms gaining prominence. LINAC systems now incorporate multi-leaf collimators (MLCs), volumetric modulated arc therapy (VMAT), and onboard imaging to deliver precise tumor targeting in fewer sessions. Proton therapy, which deposits most of its energy at the Bragg peak, is witnessing rapid adoption in pediatric oncology and complex tumor cases due to its minimal collateral damage and reduced long-term toxicity.

Furthermore, motion management techniques such as respiratory gating and real-time tumor tracking are being incorporated to address organ movement during therapy, particularly in lung and gastrointestinal cancers. Brachytherapy is gaining renewed interest for cervical, prostate, and breast cancers, thanks to its high dose localization and shortened treatment duration. Integration of MRI and PET imaging into planning systems enhances tumor delineation and adaptive treatment planning. Additionally, emerging radiopharmaceuticals in targeted radionuclide therapy are expanding treatment options for metastatic cancers, particularly in prostate and neuroendocrine tumors.

How Are Hospitals and Cancer Centers Adapting to the Radiation Oncology Revolution?

Radiation oncology departments are undergoing significant upgrades to accommodate new technologies, workflow automation, and multidisciplinary integration. Hospitals are investing in hybrid operating suites, advanced treatment planning software, and oncology information systems (OIS) to streamline patient data management and outcome tracking. Additionally, collaborations between radiation oncologists, medical physicists, dosimetrists, and IT professionals are being formalized into cross-functional teams to optimize treatment planning and delivery. Academic medical centers are leading the charge in deploying AI-guided adaptive planning tools and cloud-based contouring platforms that enhance precision while reducing planning time.

Training and workforce development are also critical components of adaptation. The complexity of modern radiotherapy requires constant upskilling in areas such as image interpretation, machine calibration, and cybersecurity for networked oncology systems. Moreover, hospitals are adopting patient-centered models that integrate psychosocial support, symptom tracking, and remote consultations into radiation oncology care pathways. Global oncology networks and tele-radiation platforms are helping extend advanced radiotherapy services to underserved regions, reducing disparities in cancer treatment access. These operational and clinical upgrades are central to radiation oncology's evolution from a procedural specialty into a fully integrated, data-driven care model.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Radiation Oncology Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Radiation Oncology Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the External Beam Radiation Therapy segment, which is expected to reach US$3.6 Billion by 2030 with a CAGR of a 3.3%. The Brachytherapy segment is also set to grow at 5.5% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $2.2 Billion in 2024, and China, forecasted to grow at an impressive 7.6% CAGR to reach $2.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Accuray Incorporated, Bionix Radiation Therapy, LLC, Brainlab AG, Canon Medical Systems Corporation, Curium and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Scope of Study:

• Treatment Type (External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy, Stereotactic Radiosurgery)
• Technology (Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology, Tomotherapy Technology)
• Application (Breast Cancer Application, Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application)
• End-Use (Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use, Ambulatory Surgery Centers End-Use)

Key Attributes:

Key Topics Covered:

MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Tariff Impact on Global Supply Chain Patterns
• Radiation Oncology - Global Key Competitors Percentage Market Share in 2025 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)

MARKET TRENDS & DRIVERS

• Rising Cancer Incidence Worldwide Throws the Spotlight on Advanced Radiotherapy Modalities
• Technological Advancements in Image-Guided Radiation Therapy Strengthen Precision Treatment Capabilities
• Expansion of Linear Accelerator Installations in Emerging Markets Drives Equipment Uptake
• Integration of Artificial Intelligence in Treatment Planning Accelerates Adoption of Adaptive Therapy Solutions
• Rising Utilization of Stereotactic Radiosurgery Expands Clinical Applications in Brain and Spine Tumors
• Growth in Proton and Heavy Ion Therapy Centers Drives Demand for High-End Oncology Infrastructure
• Collaborations Between Research Institutions and Hospitals Fuel Personalized Oncology Approaches
• Favorable Reimbursement Policies for Radiation Oncology Procedures Sustain Market Accessibility
• Growing Adoption of Hypofractionated Radiotherapy Enhances Patient Convenience and Throughput
• Emergence of Real-Time Tumor Tracking and Motion Management Improves Clinical Outcomes
• Rising Investments in Hybrid Radiotherapy Systems Strengthen Business Case for Multi-Modality Platforms
• Expansion of Cancer Care Networks and Outreach Programs Boosts Regional Equipment Penetration
• Increased Focus on Pediatric Radiation Safety Drives Innovation in Dose Optimization Tools
• Partnerships With Academic Medical Centers Accelerate Development of Evidence-Based Protocols
• Government Grants for Cancer Treatment Infrastructure Upgrade Promote Public Hospital Modernization
• Shift Toward Outpatient Radiotherapy Centers Enhances Equipment Turnaround and Affordability
• Development of Cloud-Based Treatment Planning Systems Improves Workflow and Collaboration
• Integration of Immunotherapy and Radiotherapy Approaches Strengthens Clinical Trial Pipelines
• Surge in Awareness Campaigns on Early Cancer Detection Supports Radiation Oncology Growth
• AI-Enabled Radiomics and Predictive Modeling Drive Precision Medicine in Radiation Treatment

FOCUS ON SELECT PLAYERS |Some of the 44 companies featured in this Radiation Oncology market report include:

• Accuray Incorporated
• Bionix Radiation Therapy, LLC
• Brainlab AG
• Canon Medical Systems Corporation
• Curium
• Eckert & Ziegler BEBIG
• Elekta AB
• GE Healthcare
• Hitachi Ltd.
• IBA (Ion Beam Applications SA)
• Isoray Inc.
• Mevion Medical Systems Inc.
• Nanobiotix
• Nordion Inc.
• Optivus Proton Therapy Inc.
• Panacea Medical Technologies Pvt. Ltd.
• RefleXion Medical
• RaySearch Laboratories AB
• Siemens Healthineers AG
• Sirtex Medical Limited
• Varian Medical Systems (Siemens)
• ViewRay Technologies, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/sn6b2f

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Radiation Oncology Market